ENGOT-cx12/GOG-3037/SNGTV-003
Trial Description:
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
Lead Cooperative Group:
Participating Groups:
Trial Number:
EudraCT Number: 2019-001655-39
Disease Site:
Cervical
Trial Status:
Recruiting
Contact person:
ivergote